ArticleFrontiers in pharmacology2020

CFTR Modulator Therapy Enhances Peripheral Blood Monocyte Contributions to Immune Responses in People With Cystic Fibrosis.

Katherine B Hisert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.